US Patent 7326708 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Merck & Co

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Merck & Co

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 4498 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
4498 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

193 All APIs, 116 USDMF, 4 CEP/COS, 7 JDMF, 23 KDMF, 33 NDC API, 16 VMF, 4 Listed APIs

193 All APIs
116 USDMF
4 CEP/COS
7 JDMF
23 KDMF
33 NDC API
16 VMF
4 Listed APIs

DEVELOPMENTS

3123 Drugs in Development

3123 Drugs in Development

FINISHED DOSAGE FORMULATIONS

3157 FDF Dossiers, 352 FDA Orange Book, 2114 Europe, 189 Canada, 220 Australia, 282 South Africa

3157 FDF Dossiers
352 FDA Orange Book
2114 Europe
189 Canada
220 Australia
282 South Africa

SERVICES

API & Drug Product Development

API & Drug Product Development
- 1 API Development

EXCIPIENTS

6 All Excipients, 2 USDMF, 4 NDC API

6 All Excipients
2 USDMF
4 NDC API

REF. STANDARDS & IMPURITIES

2 Others

2 Others

INSPECTIONS & REGISTRATIONS

170 FDA, 10 EDQM, 1 Third-Party Audit

170 FDA
10 EDQM
1 Third-Party Audit

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

16 All

01 9MERCK SHARP DOHME

02 7MSD SUB MERCK

filter Patent Number Reset all filters

16 All

01 167326708

filter API Patent Reset all filters

16 All

01 16Y

filter FDF Patent Reset all filters

16 All

01 16Y

filter Expiration Date Reset all filters

16 All

01 62026-04-11

02 102026-11-24

01

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

BePharma

Not Confirmed

MERCK SHARP DOHME

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

MERCK SHARP DOHME

SITAGLIPTIN PHOSPHATE

BePharma

Not Confirmed

MERCK SHARP DOHME

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21995

Patent Use Code : U-802

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

BePharma

Not Confirmed

MERCK SHARP DOHME

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

BePharma

Not Confirmed

MERCK SHARP DOHME

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

MERCK SHARP DOHME

SITAGLIPTIN PHOSPHATE

BePharma

Not Confirmed

MERCK SHARP DOHME

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21995

Patent Use Code : U-802

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

BePharma

Not Confirmed

MERCK SHARP DOHME

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

BePharma

Not Confirmed

MERCK SHARP DOHME

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

MERCK SHARP DOHME

SITAGLIPTIN PHOSPHATE

BePharma

Not Confirmed

MERCK SHARP DOHME

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21995

Patent Use Code : U-802

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

BePharma

Not Confirmed

MERCK SHARP DOHME

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

MSD SUB MERCK

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

BePharma

Not Confirmed

MSD SUB MERCK

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209805

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.